Tumor budding, an important prognostic factor in stage III colon cancer patients treated with oxaliplatin-based chemotherapy

被引：0
|
作者：
Basile, D. [1 ,2 ,3 ]
Broudin, C. [4 ,5 ]
Emile, J-F. [6 ,7 ]
Falcoz, A. [8 ]
Toullec, C. [9 ]
Bennouna, J. [10 ]
Louvet, C. [11 ]
Desrame, J. [12 ]
Fratte, S. [13 ,14 ]
Andre, T. [15 ]
Taieb, J. [16 ]
Svrcek, M. [17 ]
机构：
[1] Univ Udine, Dept Med DAME, Dept Hepatogastroenterol & Gastrointestina, Paris, France
[2] ULSS8 Ber, Dept Med Oncol, Vicenza, Italy
[3] Univ Paris Paris Descartes, Hop Europeen Georges Pompidou, AP HP, CARPEM,SIRIC, Paris, France
[4] Assistance Publ Hop Paris AP HP Ctr, Serv Anatomopathol Hop Europeen Georges Pompi, Paris, France
[5] Univ Paris, Fac Med, Paris, France
[6] Versailles Saint Quentinen Yvelines Univ, EA4340 Biomarqueurs & Essais Clin Cancerol & Onco, Dept Pathol, Boulogne, France
[7] Hop Ambroise Pare, AP HP, Boulogne, France
[8] Univ Bourgogne Franche Comte, INSERM, Etab Francais Sang Bourgogne Franche, UMR 1098,Methodol & Quality Life Unit Oncol, Besancon, France
[9] Inst St Catherine, Dept Digest Oncol, Avignon, France
[10] CHU Nantes, Digest & Lung Oncol Dept, Nantes, France
[11] Inst Mutualiste Montsouris, Oncol, Paris, France
[12] Hop Prive Jean Mermoz, Oncol, Lyon, France
[13] Hosp Belfort Montbeliard, Montbeliard, France
[14] Hosp Besancon, Besancon, France
[15] Hop St Antoine, Med Oncol, Paris, France
[16] Hop European George Pompidou, Gastroenterol & Digest Oncol Dept, Paris, France
[17] Sorbonne Univ, Hop St Antoine, Pathol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.910
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
388MO
引用
收藏
页码：S533 / S533
页数：1
相关论文
共 50 条
  • [1] Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy
    Gallois, C.
    Taieb, J.
    Le Corre, D.
    Le Malicot, K.
    Tabernero, J.
    Mulot, C.
    Seitz, J-F.
    Aparicio, T.
    Folprecht, G.
    Lepage, C.
    Mini, E.
    Van Laethem, J-L.
    Emile, J. F.
    Laurent-Puig, P.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [2] Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy
    Gallois, Claire
    Taieb, Julien
    Le Corre, Delphine
    Le Malicot, Karine
    Tabernero, Josep
    Mulot, Claire
    Seitz, Jean-Francois
    Aparicio, Thomas
    Folprecht, Gunnar
    Lepage, Come
    Mini, Enrico
    Van Laethem, Jean-Luc
    Emile, Jean-Francois
    Laurent-Puig, Pierre
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4745 - 4753
  • [3] Effect of Delay in Adjuvant Oxaliplatin-Based Chemotherapy for Stage III Colon Cancer
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel
    Kennecke, Hagen F.
    Lim, Howard J.
    Cheung, Winson Y.
    Melosky, Barbara
    Gill, Sharlene
    [J]. CLINICAL COLORECTAL CANCER, 2015, 14 (01) : 25 - 30
  • [4] Organic cation transporter 2 and tumor budding as independent prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Tatsumi, Shigenobu
    Matsuoka, Hiroshi
    Hashimoto, Yumi
    Hatta, Kohei
    Maeda, Kotaro
    Kamoshida, Shingo
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (01): : 204 - 212
  • [5] Impact of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel John
    Kennecke, Hagen F.
    Lim, Howard John
    Cheung, Winson Y.
    Melosky, Barbara L.
    Gill, Sharlene
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Oxaliplatin-Based Chemotherapy for Colon Cancer
    Bonetti, Andrea
    Furini, Lara
    [J]. PLATINUM AND OTHER HEAVY METAL COMPOUNDS IN CANCER CHEMOTHERAPY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, 2009, : 271 - 284
  • [7] Validation of genetic markers for prognosis in colon cancer patients treated with oxaliplatin-based chemotherapy
    Park, Hanla
    Seibold, Petra
    Edelmann, Dominic
    Benner, Axel
    Jansen, Lina
    Canzian, Federico
    Schneider, Martin
    Hoffmeister, Michael
    Brenner, Hermann
    Chang-Claude, Jenny
    [J]. GENETIC EPIDEMIOLOGY, 2020, 44 (05) : 509 - 509
  • [8] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [9] phase II study of oxaliplatin-based regimen in relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: INSPIRE study
    Kotaka, M.
    Ishibashi, K.
    Satake, H.
    Tsuji, Y.
    Kataoka, M.
    Nakamura, M.
    Nagata, N.
    Sakamoto, J.
    Oba, K.
    Mishima, H.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S101 - S101
  • [10] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Keiichiro Ishibashi
    Toru Aoyama
    Masahito Kotaka
    Hironaga Satake
    Yasushi Tsuji
    Masato Kataoka
    Masato Nakamura
    Naoki Nagata
    Junichi Sakamoto
    Koji Oba
    Hideyuki Mishima
    [J]. Cancer Chemotherapy and Pharmacology, 2021, 87 : 665 - 672
12345